DEBBANE RAYMOND 4
4 · LEXICON PHARMACEUTICALS, INC. · Filed Oct 12, 2023
Insider Transaction Report
Form 4
DEBBANE RAYMOND
Director
Transactions
- Purchase
Common Stock
2023-10-11$1.08/sh+342,874$370,784→ 1,192,027 total - Purchase
Common Stock
2023-10-10$1.14/sh+508,306$579,367→ 849,153 total - Purchase
Common Stock
2023-10-12$1.03/sh+148,820$153,805→ 1,340,847 total
Holdings
- 5,451,204(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.09 to $1.19 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $1.06 to $1.12 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $1.02 to $1.07 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected.